We are live on ! Find out more
IDIX

IDENIX PHARMACEUTICALS INC
IDIX

Delisted

IDIX was delisted on the 5th of August, 2014.

Back to rankings

96 hedge funds and large institutions have $695M invested in IDENIX PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more call options, than puts

Call options by funds: $9.08M | Put options by funds: $3.51M

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

11% more capital invested

Capital invested by funds: $628M → $695M (+$67.8M)

9% more funds holding

Funds holding: 88 → 96 (+8)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
2.77%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
20
Increased
31
Reduced
24
Closed
12
Calls
$9.08M
Puts
$3.51M
Net Calls
+$5.57M
Net Calls Change
+$307K

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$115M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.87M
3
OAM
Oxford Asset Management
United Kingdom
+$4.89M
4
BFA
BlackRock Fund Advisors
California
+$4.64M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.15M

Top Sellers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$28.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.42M
3
BM
Bridger Management
New York
-$5.23M
4
FAM
Fred Alger Management
New York
-$3.51M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.92M +$252K +36,144 +13%
Charles Schwab
27
Charles Schwab
California
$1.69M -$49.9K -7,153 -2%
CNB
28
City National Bank
California
$1.51M – – –
ProShare Advisors
29
ProShare Advisors
Maryland
$1.38M +$1.14M +162,849 +246%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$1.23M +$160K +22,900 +13%
CS
31
Credit Suisse
Switzerland
$1.18M +$28.6K +4,103 +2%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$1.17M -$433K -62,129 -24%
Morgan Stanley
33
Morgan Stanley
New York
$1.12M -$158K -22,639 -11%
OWIM
34
Old West Investment Management
California
$1.07M +$321K +46,036 +35%
AllianceBernstein
35
AllianceBernstein
Tennessee
$1.04M -$60.7K -8,700 -5%
TA
36
Teachers Advisors
New York
$1M +$167K +23,890 +17%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$994K -$94.1K -13,500 -8%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$956K -$3.35M -479,794 -75%
U
39
UBS
Switzerland
$930K +$330K +47,380 +44%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$742K – – –
Group One Trading
41
Group One Trading
Illinois
$684K +$791K +113,475 New
FAM
42
Fred Alger Management
New York
$674K -$3.51M -503,262 -82%
Swiss National Bank
43
Swiss National Bank
Switzerland
$595K – – –
SCA
44
SAC Capital Advisors
Connecticut
$579K +$573K +82,100 +591%
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$560K +$114K +16,300 +21%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$552K +$101K +14,447 +19%
Deutsche Bank
47
Deutsche Bank
Germany
$490K +$109K +15,646 +24%
NFA
48
Nationwide Fund Advisors
Ohio
$488K +$27.2K +3,904 +5%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$483K -$4.88K -700 -0.9%
BA
50
BlackRock Advisors
Delaware
$472K +$78.7K +11,288 +17%
1
2
3 4 5

IDIX Hedge Fund Activity: Q1 2014 in Review

96 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q1 2014, worth a combined $695M — up 11% from $628M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IDIX positions and 12 closed out — a net gain of 8 holders — while 31 added to existing stakes and 24 trimmed.

The largest buyer was Baupost Group, adding an estimated $115M. The largest seller was Bain Capital Public Equity Management, cutting an estimated $28.7M.

  • 96 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q1 2014, up from 88 in Q4 2013.
  • Funds reported $695M of IDENIX PHARMACEUTICALS INC stock for Q1 2014, up 11% quarter-over-quarter.
  • 20 funds opened new IDENIX PHARMACEUTICALS INC positions in Q1 2014 and 12 closed out, a net change of +8 holders.
  • The largest IDENIX PHARMACEUTICALS INC buyer in Q1 2014 was Baupost Group, an estimated $115M added.
  • The largest IDENIX PHARMACEUTICALS INC seller in Q1 2014 was Bain Capital Public Equity Management, an estimated $28.7M sold.

Based on aggregated 13F filings for Q1 2014.